baber/WOPTO huggingface dataset:
Patent ES-534873-A0 (ES)
IPC: B27F7/02
Filed: 1984-08-03
Abstract: The invention relates to a device for assembling mouldings incorporating several rabbets, which comprises a table for positioning the mouldings, slides supporting this table, rendered fast with two columns which are connected in their lower part by a base under which is mounted a jack whose rod is connected to a hammer which penetrates in a clip magazine, and in their upper part by a piece provided with a presser member located opposite the hammer. According to the invention, a clipping assembly is provided which bears the hammer and a sliding guide fast with the hammer, as well as a sensor; two small columns on which the clipping assembly may slide vertically; balancing means mounted on each small column below the clipping assembly; and a plate disposed at the top of the rod, and on which the hammer and the sliding guide rest, and which comprises a matching member opposite the sensor. The invention is more particularly applicable to the manufacture of wooden frames.
Patent ES-554285-A0 (ES)
IPC: C07D409/12
Filed: 1986-04-23
Abstract: The invention relates to N-indolylethyl-sulphonic acid amides of the formula   <IMAGE>   wherein R1, R2, R3, R4 and R5 are defined in the specification and X is carboxyl, alkoxycarbonyl, cyano or carboxamido. These active compounds are useful in medicaments in combating thromboses, thromboembolisms, allergies or asthmatic disorders.
Patent ES-556096-A0 (ES)
IPC: C07D417/12
Filed: 1986-06-16
Abstract: Novel optical isomers and racemates of 4-hydroxy-3-quinoline-carboxylates of the formula    <IMAGE>  I wherein X is in the 5-, 6-, 7- or 8-position and is selected from the group consisting of hydrogen, halogen, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 4 carbon atoms, -CF3, -SCF3 and -OCF3, R1 is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, R2 is selected from the group consisting of thiazolyl, 4,5-dihydrothiazolyl, pyridinyl, oxazolyl, isoxazolyl, imidazolyl, pyrimidyl and tetrazolyl all optionally substituted with alkyl of 1 to 4 carbon atoms and phenyl substituted with at least one member of the group consisting of -OH, alkyl and alkoxy of 1 to 4 carbon atoms, -CF3, -NO2 and halogen, R3 and R4 are individually selected from the group consisting of hydrogen, alkyl of 1 to 4 carbon atoms and aryl, R5 is selected from the group consisting of aryl of 6 to 14 carbon atoms, heteroaryl of 3 to 14 carbon atoms, alkyl of 1 to 14 carbon atoms, alkyl substituted with -NH2, -NHAlk or    <IMAGE>   alkenyl of 2 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms substituted with aryl of 6 to 14 carbon atoms, Alk and Alk' are alkyl of 1 to 6 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts with the proviso that when X is 8-CF3, R1 and R3 are hydrogen, R2 is 2-thiazolyl, R4 is methyl, R5 is not methyl having analgesic and anti-inflammatory activity.
Patent FI-823743-A0 (FI)
Inventor: DYRIG HEINZ
IPC: E06B9/36
Filed: 1982-11-02
Abstract: The strip curtain has a plurality of glide elements which are guided by a curtain rod and connected with each other by separation-limiting devices. The free hanging curtain strips are suspended from vertical pivot axes with limited excursion. Operation of the pivot axis is by a pinion which engages a bead chain that is slidably guided by the curtain rod. The pinion is connected to the pivot axis by a worm drive, a slip coupling being provided between the pinion and the worm drive. The bead chain serves as common drive for producing pivotal movement and sliding movement of the curtain strips. The strip curtain is of simple construction and therefore reliable in operation and inexpensive and suitable for mass production.
Patent FI-831457-A0 (FI)
Inventor: KISHIMOTO SHOJI
IPC: C07D311/22
Filed: 1983-04-28
Abstract: A 1-sulfo-2-oxoazetidine derivative of the formula <CHEM> wherein R<a> is -COQ<0> (Q<0> is an amino group which may optionally be protected or substituted), -COQ<5> (Q<5> is a hydroxyl group which may optionally be protected), -(CH2)na- R<4a> (n<a> is an integer of 1 to 3; R<4a> is a hydrogen atom or a carbamoylamino, N-sulfocarbamoylamino, carbamoyl, carbamoyloxy, N-sulfocarbamoyloxy, haloalkylcarbonylcarbamoyloxy, alkylsulfonyloxy, pyridinio, alkoxy, alkylsulfinyl, alkylsulfonyl, halogenoalkylcarbonyloxy, hydroxyl, alkoxycarbonyl, acyloxy, 1-alkoxyiminoalkyl, alkylcarbony or acylamino group) or a nitrogen-containing heterocyclic group; R<1> is an amino group which may optionally be acylated or protected; and X is a hydrogen atom or a methoxy group, or a salt or ester thereof, and methods of producing said compound (I<a>) which may be shown as follows <CHEM> wherein the symbols have the same meanings as respectively defined above, and intermediates for preparing the compound (I<a>) and methods of producing them. The compound (I<a>) has improved antimicrobial and  beta -lactamase-inhibitory activities and is of value as drugs for human beings and domesticated animals.
Patent FI-841255-A0 (FI)
Inventor: COLLINS DOUGLAS NEIL
IPC: B03D1/02
Filed: 1984-03-29
Abstract: Ores of metal oxides and oxide-like compounds such as chromite and pyrochlore are beneficiated by froth flotation in the presence of substituted amino phosphonic acids or salts thereof.
Patent FI-870959-A0 (FI)
Inventor: JANICKE REINHARD
IPC: A01N43/84
Filed: 1987-03-04
Abstract: 1. A composition for controlling phytopathogenic fungi and for preventing fungus attack based on a mixture of two plant fungicides in admixture with a suitable carrier and/or extender, wherein the composition contains as component l the active ingredient 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylme- thyl]-1H- 1,2,4-triazol (= propiconazol) of formula l   see diagramm : EP0237483,P7,F1   or a salt thereof and as component ll the active ingredient 4-[3-(4-tert. butylphenyl)-2-methylpropyl]-cis-2,6-dimethylmorpholine (= fenpropimorph) of formula ll   see diagramm : EP0237483,P7,F2   or a salt thereof in an amount producing synergistic fungicidal activity.
Patent FI-895093-A0 (FI)
Inventor: OBERDOERFER HANS
IPC: E03C1/10
Filed: 1989-10-26
Abstract: An anti-syphoning valve (12) which is suitable especially for incorporation into sanitary fittings comprises, in a housing (1), a chamber (10) into which a water inlet conduit (9), a water outlet conduit (8) and a ventilation channel lead. A resilient closing flap (16) comprises a fastening portion (18) and a closing portion (19) connected hinge-like thereto. Normally, that is, provided there is no negative pressure in the inlet conduit, the closing portion covers the opening of the ventilation channel leading into the chamber, so that, on the one hand, no atmospheric air can enter and, on the other hand, no water can escape. If, however, a negative pressure arises in the pipe system connected to the inlet conduit, the closing portion of the closing flap pivots through a certain angle until it seals the inlet point of the conduit leading into the chamber and, on the other hand, frees the ventilation channel to the chamber. In this way, no more water can flow back into the inlet conduit and to the pipe system connected thereto; on the other hand, the water passages downstream of the chamber are ventilated. The sucking back of contaminated water into the drinking-water system which is connected to the inlet conduit is thereby reliably prevented. The anti-siphoning valve is of such small construction that it can be accommodated especially in the bottom region of known sanitary fittings. 
<IMAGE>
Patent FI-914535-A0 (FI)
Inventor: EGBERTSON MELISSA S
IPC: A61K31/40
Filed: 1991-09-26
Abstract: A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
Patent FI-940649-A0 (FI)
Inventor: DESMARAIS THOMAS ALLEN
IPC: C08F212/08
Filed: 1994-02-11
Abstract: Disclosed are absorbent foam materials suitable for use as or in the absorbent cores of absorbent articles, such as diapers which absorb and retain aqueous body fluids. Such foam materials comprise hydrophilic, flexible open-celled structures which are preferably prepared by polymerizing high internal phase (HIPE) water-in-oil emulsions. Such foam materials have a pore volume of from about 12 to 100 mL/g, and a capillary suction specific surface area of from about 0.5 to 5.0 m2/g. These materials also exhibit a resistance to compression deflection such that a confining pressure of 5.1 kPa produces after 15 minutes a strain of from about 5% to 95% compression when the material is saturated at 37 DEG  C. to its free absorbent capacity with synthetic urine.
Patent FI-944715-A0 (FI)
Inventor: MILNE JOHN DE COURCEY
IPC: A63C17/12
Filed: 1994-10-07
Abstract: PCT No. PCT/AU93/00161 Sec. 371 Date Oct. 11, 1994 Sec. 102(e) Date Oct. 11, 1994 PCT Filed Apr. 8, 1993 PCT Pub. No. WO93/20911 PCT Pub. Date Oct. 28, 1993A sports conveyance is disclosed having a frame mounted on a pair of spaced front wheels and also supported by rear wheel means, the front wheels having interconnecting means whereby they may be turned in unison to either side of the longitudinal center line of the conveyance, a board mounted on the frame to support a rider and adapted to be depressed at a respective side of the longitudinal center line of the conveyance, said board being adapted to be disposed in a substantially horizontal position with the front wheels unturned but so connected to the interconnecting means of the front wheels that depression of the board by body weight of the rider at a respective side of the board causes turning of the wheels in unison in the respective direction upon movement of the board.
Patent IL-62386-A0 (IL)
Title: Quinuclidinic esters of phenoxycarboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
IPC: A61P3/06
Filed: 1981-03-16
Abstract: The invention relates to esters of 3-hydroxy-quinuclidine with phenoxycarboxylic acids, and their salts having general formula:wherein R<sub>1</sub> represents H,CH<sub>3</sub>, and R<sub>2</sub> represents H,CI,Br or a radical of an acid of the group comprising oleic, pivalic, nicotinic, clofibric, pyridineacetic and teophyllineacetic acid.The compounds of the invention jointly show hypocholesteremizing and hypotriglyceridimizing activity, combined with other therapeutically interesting properties, such as beta-blocking, diuretic, anti--inflammatory activity.The invention furthermore relates to the pharmaceutical compositions containing the compounds of the invention as the active ingredients.
Patent IL-69687-A0 (IL)
Title: Three-dimensional reticulated structure with rods having tapered ends
IPC: E04B1/19
Filed: 1983-09-07
Abstract: @ A three-dimensional reticulated structure or space lattice structure is formed of metal rods (1) tapered at their ends so that the loss of cross-section leads to a thickening of the tubular wall (2) of the rod, whereby it can be threaded at its ends (1a) by removal of material without losing mechanical strength. This is preferably attained by coining through at least six successive passes in dies of increasingly smaller dimensions. The knots or junctions are bored metal cups (3), said rods (1) converging into the bores thereof and being fixed simply by bolts (4). A plug (7) of concrete reinforced with steel fibres closes the base of the cup (3) while allowing its reopening for inspection and maintenance, and provides further mechanical strength to the assembly.
Patent IL-98197-A0 (IL)
Title: Fibrin binding domain polypeptides and uses and methods of producing same
IPC: C07K14/315
Filed: 1991-05-21
Abstract: This invention provides an imaging agent which comprises a polypeptide labeled with an imageable marker, such polypeptide having an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and being capable of binding to fibrin. The invention further provides a method wherein the imaging agent is used for imaging a fibrin-containing substance, i.e., a thrombus or atherosclerotic plaque. Further provided are plasmids for expression of polypeptides having an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and being capable of binding to fibrin, hosts containing these plasmids, methods of producing the polypeptides, methods of treatment using the polypeptides, and methods of recovering, refolding and reoxidizing the polypeptides. The invention also provides for purified polypeptides substantially free of other substances of human origin which have an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and which are capable of binding to fibrin.
Patent IL-99759-A0 (IL)
Title: Mono-fluorinated derivatives of n-propargyl-1-aminoindan and their use as inhibitor of monoamine oxidase
IPC: A61P43/00
Filed: 1991-10-16
Abstract: N-propargyl-1-amonoindan monofluorinated in the phenyl ring and their use as selective inhibitors of monoamine oxidase (MAO). There are provided several processes for the preparation of these novel compounds. There are also provided as novel compounds 1-aminoindans monofluorinated in the phenyl ring, which serve as intermediates in the preparation of the corresponding novel N-propargyl derivatives.
Patent SE-7904022-A0 (SE)
Title: Anordning för eldning med fasta bränslen
Inventor: SJUNNE JOHANSSON
IPC: F23J1/02
Filed: 1979-05-08
Abstract: Cenom uppfinningen onskar man erhAlla en eldningsanordning for fasta brAnslen, sAsom exempelvis ved, trAflis, hark, sAgspAn, tory och liknande, av det slag vid yilket I. eldstaden ar anordnad en med luftgenoms1apps6p2ninar utfOrd, frAn eldstadens brAnsleinmatningsstalle till dess avfallsutmatningsstalle sig strackande rost (2), vilken ger en sA god for--doming at, brAnslet och en sA effektiy slutforbranning av detmamma som mojligt. Den enligt uppfinningen utfOrda anordningen uppvisar en rost, som sluttar frAn brAnsleinmatningsstAllet till bransleutmatningsstAllet, och ett antal i rostens tyArriktning,
Patent AU-PR390301-A0 (AU)
Title: Wine barrel filling apparatus
IPC: B67D7/46
Filed: 2001-03-22
Abstract: An apparatus (1) for filling a wine barrel is disclosed. The apparatus has a nozzle (4) connected to a hollow handle (15) where the upstream portion of the handle is connected to a hose from a wine supply. Supply of wine in the apparatus is controlled by a control button (17) on the handle (15) which opens an upstream solenoid valve. The apparatus (1) has a locating lug (6) and arm (7) on the nozzle portion to allow generally vertical location of the nozzle in a barrel bung hole. The apparatus has a non-return valve (14) to prevent wine flowing from the hose to the apparatus when the upstream solenoid valve is closed. The apparatus has a conductivity sensor (9) to cause closure of the upstream solenoid valve when the wine in the barrel reaches a predetermined level.
Patent FI-20021464-A0 (FI)
Inventor: HARTIKAINEN ARI
IPC: H01R13/66
Filed: 2002-08-12
Abstract: The invention relates to a socket assembly, comprising a socket frame (10), a socket-outlet along with its cover plate (9) fitted therein, connectors (7,8) present at the opposite ends of the socket assembly, which are compatible with connectors (8,7) present at the end of an adjacent socket assembly or a cable and which have poles (L1,L2,L3) for three-phase linking. The connectors (7,8) present at the opposite ends of the socket assembly have their poles (L1,L2,L3) for three-phase linking precoupled with each other by rotating a position of the phases. <IMAGE>
Patent FI-20070196-A0 (FI)
Inventor: IKONEN JANNE
IPC: F28F/
Filed: 2007-03-07
Abstract: In the arrangement in a heat exchanger in accordance with the invention, the heat exchanger comprises a shell and tubes. The tubes are placed inside the shell. The first medium entering the heat exchanger can be conducted into the tubes and the second medium between the inner shell surface and outer tube surface, and the first medium from the heat exchanger can be conducted out from the tubes and the second medium out from between the inner shell surface and outer tube surface. The heat exchanger comprises at least two tube rows placed in succession in the direction of the second medium's flow. The first tube row comprises at least two tubes, the first distance being between the two parallel tubes, the second distance being between the first parallel tube in the first row and a tube in the second row, and the third distance is between the second parallel tube in the first row and the tube in the second row. The first, second and third distances form a triangle, each angle of which is smaller than 90° and the second distance is a different length from the third distance.
Patent IL-104009-A0 (IL)
Title: Process for preparing ketone enantiomer
IPC: C07C67/343
Filed: 1992-12-07
Abstract: A novel multi-step process for preparing the (4S &cir& _-enantiomer of 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone in a highly-optically pure form is disclosed. The process involves (1) first esterifying 4-(3,4-dichlorophenyl)-4-ketobutanoic acid with isopropylene or isobutylene to form the corresponding isopropyl or t &cir& _e &cir& _r &cir& _t &cir& _.-butyl 4-(3,4-dichlorophenyl)-4-ketobutanoate; (2) then reducing the ketobutanoic acid ester obtained in the first step with an asymmetric carbonyl reducing agent to form the corresponding chiral isopropyl or t &cir& _e &cir& _r &cir& _t &cir& _.-butyl 4-(3,4-dichlorophenyl)-(4R &cir& _)-hydroxybutanoate; (3) then sulfonylating the (4R &cir& _)-hydroxybutanoic acid ester with methanesulfonyl, benzenesulfonyl or p &cir& _-toluenesulfonyl chloride or bromide in the presence of a standard base to yield the corresponding isopropyl or t &cir& _e &cir& _r &cir& _t &cir& _.-butyl 4-(3,4-dichlorophenyl)-(4R &cir& _)-sulfonyloxybutanoate; (4) next subjecting the 4-sulfonyloxybutanoic acid ester obtained in the third step to a copper-coupling reaction with dilithium diphenyl(cyano)cuprate of the formula  PHI 2Cu(CN)Li2 to effect a stereochemical displacement of the organic (4R &cir& _)-sulfonyloxy group of the (4R &cir& _)-sulfonyloxybutanoic acid ester by the phenyl group of the dilithium diphenylcuprate reagent and so selectively form the corresponding isopropyl or t &cir& _e &cir& _r &cir& _t &cir& _.-butyl 4-(3,4-dichlorophenyl)-(4R &cir& _)-phenylbutanoate, and (5) thereafter cyclizing the stereospecific (4R &cir& _)-phenylated n-butanoic acid ester in the presence of a protic or Lewis acid catalyst to finally yield the desired (4S &cir& _)-4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone compound in a highly-optically pure form. The latter compound, which is a novel (4S &cir& _)-enantiomer per se, has utility as an intermediate that ultimately leads to pure c &cir& _i &cir& _s &cir& _-(1S &cir& _)(4S &cir& _)N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine (sertraline), which is a known antidepressant agent. The aforementioned isopropyl and t &cir& _e &cir& _r &cir& _t &cir& _.-butyl esters of 4-(3,4-dichlorophenyl)-(4R &cir& _)-hydroxybutanoic acid, as well as their corresponding (4R &cir& _)-methanesulfonyl, (4R &cir& _)-benzenesulfonyl and (4R &cir& _)-p &cir& _-toluenesulfonyl derivatives, are also novel compounds, as are the aforementioned isopropyl and t &cir& _e &cir& _r &cir& _t &cir& _.-butyl esters of 4-(3,4-dichlorophenyl)-(4R &cir& _)-phenylbutanoic acid as well as the aforesaid acid per se. These novel chiral compounds are all useful as key intermediates in the overall process of the present invention.
Patent IL-106908-A0 (IL)
Title: Condensed heterocyclic compounds,their production and use
IPC: C07D241/52
Filed: 1993-09-03
Abstract: Novel compound represented by the formula: <CHEM>  wherein ring A may be substituted;  ring B represents an optionally substituted benzene ring; either X or Y represents -NR<1>- (R<1> represents a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted hydroxyl group or an optionally substituted amino group), -O- or -S-, the other representing -CO-, -CS- or -C(R<2>)R<2a>- (R<2> and R<2a> independently represent a hydrogen atom or an optionally substituted hydrocarbon group), or either X or Y represents -N=, the other representing =CR<3>- (R<3> represents a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group , an optionally substituted amino group, a substituted hydroxyl group or a mercapto group substituted by an optionally substituted hydrocarbon group);  <........> represents a single or double bond; when <........> is a single bond, Z represents -CR<4>- (R<4> represents a hydrogen atom, hydroxyl group or an optionally substituted hydrocarbon group) or a nitrogen atom, or (ii) when <........> is a double bond, Z represents a carbon atom; D represents a C1-3 alkylene group which may be substituted by an oxo group or a thioxo group, or D and Y, taken together, may form a 5- to 7-membered ring which may be substituted by an oxo group or a thioxo group; E represents -NR<5>- (R<5> represents a hydrogen atom or an optionally substituted hydrocarbon group), -O- or -S(O)n- (n is 0,1 or 2), or R<5> and Y, taken together, may form a 5- to 7- membered ring which may be substituted by an oxo group or a thioxo group;  G represents a bond or a C1-3 alkylene group; Ar represents an optionally substituted aryl group or an optionally substituted heterocyclic group, provided that (1) when (i) -X-Y- represents - O-CO- or -CO-O-, (ii) D represents -CO- and (iii) E represents -NR<5>-, either (a) G represents a C1-3 alkylene group and Ar represents a substituted aryl group or a substituted heterocyclic group, or (b) G represents a bond and R<5> represents an optionally substituted hydrocarbon group, and (2) when -X-Y- represents -NH-CO-, D represents -CO-, or a salt thereof having an excellent activity of inhibiting ACAT, lowering chlesterol in blood and inhibiting tachykinin recepter, or a salt thereof, their production and use.
Patent IL-107232-A0 (IL)
Title: 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IPC: A61P15/00
Filed: 1993-10-11
Abstract: In this invention, the new etheno- and ethano-19,11-bridged 4-estrenes of general formula I    <IMAGE>  (I)  are described, in which W, R1, R2, R6a, R6b, R7, R14, R15, R16, R11, R11' and R19 have the meaning indicated in the description, as well as a process for their production. The new compounds have strong progestational activity and are suitable for the production of pharmaceutical agents.
Patent IL-107439-A0 (IL)
Title: Flanging apparatus particulary for hollow articles obtained by thermoforming sheet material
IPC: B29C51/18
Filed: 1993-10-28
Abstract: Flanging or curling apparatus particularly for hollow articles (15) obtained by thermoforming from thermoformable sheet material for use in a thermoforming plant equipped with template or mask conveyor (4) for transfer of the thermoformed objects (15). The apparatus comprises a support frame (2) which delimits at least one workstation for a sequence of masks (3) supporting hot thermoformed objects (15) carried by the conveyor (4) or at least one head for simultaneous curling of all thermoformed objects (15) in the or each workstation.
Patent IL-107944-A0 (IL)
Title: Pyrazolopyrimidines
IPC: A61P37/06
Filed: 1993-12-09
Abstract: A compound of the formula:and the pharmaceutically acceptable acid addition salts thereof, whereinA is NR1R2, CR1R2R11, or C(=CR1R12)R2, NHCR1R2R11, OCR1R2R11, SCR1R2R11, NHNR1R2, CR2R11NHR1, CR2R11OR1, CR2R11SR1 or C(O)R2;wherein the rest of the variables are herein below defined, used for inflammatory disorders.